Abpro Bio International, Inc.
CIK: 0002044844
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
Abpro Holdings, Inc.
Discretionary Trading P&L
Holdings
Transaction History (0 total)
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| 1 Form 3 filing on record — initial statements of ownership, which report holdings, not trades. No Form 4 or Form 5 transactions since Sep 2024. | ||||||
0-0 of 0 transactions
Abpro Bio International, Inc. files insider reports with the SEC as 10% Owner of Abpro Holdings, Inc. (ABP).
About Abpro Bio International, Inc.
Abpro Bio International, Inc. (SEC CIK 0002044844) files insider reports with the SEC as 10% Owner of Abpro Holdings, Inc. (ABP).
Signal8 holds 1 ownership filing by Abpro Bio International, Inc., a Form 3, filed on Nov 18, 2024. A Form 3 is an initial statement of ownership: it reports holdings, not trades, so no Form 4 or Form 5 transactions are on record since Sep 2024.
The business address on Abpro Bio International, Inc.'s filings is in DAEGU, M5.
Other insiders filing for Abpro Holdings, Inc. (ABP)
- Lee Soo Young, Director
- Suk Jin Wook (Miles), Co-CEO & Chairman
- Eisenberg Anthony D., Director
- Chan Ian, Chief Executive Officer
- McDonald Ian, Director
- Markelewicz Robert J. Jr., Chief Medical Officer